PMC:7317273 / 20999-21164
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T107","span":{"begin":135,"end":153},"obj":"Disease"}],"attributes":[{"id":"A107","pred":"mondo_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/MONDO_0002771"}],"text":"Likewise, hypoxia preconditioning can also improve the proliferation and therapeutic efficacy of MSCs, as evident in bleomycin-induced pulmonary fibrosis model [36]."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T246","span":{"begin":161,"end":163},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"}],"text":"Likewise, hypoxia preconditioning can also improve the proliferation and therapeutic efficacy of MSCs, as evident in bleomycin-induced pulmonary fibrosis model [36]."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T84","span":{"begin":117,"end":126},"obj":"Chemical"}],"attributes":[{"id":"A84","pred":"chebi_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/CHEBI_22907"}],"text":"Likewise, hypoxia preconditioning can also improve the proliferation and therapeutic efficacy of MSCs, as evident in bleomycin-induced pulmonary fibrosis model [36]."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"327","span":{"begin":117,"end":126},"obj":"Chemical"},{"id":"335","span":{"begin":10,"end":17},"obj":"Disease"},{"id":"336","span":{"begin":135,"end":153},"obj":"Disease"}],"attributes":[{"id":"A327","pred":"tao:has_database_id","subj":"327","obj":"MESH:D001761"},{"id":"A335","pred":"tao:has_database_id","subj":"335","obj":"MESH:D000860"},{"id":"A336","pred":"tao:has_database_id","subj":"336","obj":"MESH:D011658"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Likewise, hypoxia preconditioning can also improve the proliferation and therapeutic efficacy of MSCs, as evident in bleomycin-induced pulmonary fibrosis model [36]."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T326","span":{"begin":0,"end":165},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Likewise, hypoxia preconditioning can also improve the proliferation and therapeutic efficacy of MSCs, as evident in bleomycin-induced pulmonary fibrosis model [36]."}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T25","span":{"begin":10,"end":17},"obj":"Phenotype"},{"id":"T26","span":{"begin":135,"end":153},"obj":"Phenotype"}],"attributes":[{"id":"A25","pred":"hp_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/HP_0012418"},{"id":"A26","pred":"hp_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/HP_0002206"}],"text":"Likewise, hypoxia preconditioning can also improve the proliferation and therapeutic efficacy of MSCs, as evident in bleomycin-induced pulmonary fibrosis model [36]."}
2_test
{"project":"2_test","denotations":[{"id":"32592163-25986930-140679197","span":{"begin":161,"end":163},"obj":"25986930"}],"text":"Likewise, hypoxia preconditioning can also improve the proliferation and therapeutic efficacy of MSCs, as evident in bleomycin-induced pulmonary fibrosis model [36]."}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T359","span":{"begin":55,"end":68},"obj":"GO:0008283"},{"id":"T360","span":{"begin":97,"end":101},"obj":"DG_47"},{"id":"T361","span":{"begin":117,"end":126},"obj":"CHEBI:22907;CHEBI:22907"},{"id":"T362","span":{"begin":135,"end":144},"obj":"UBERON:0002048"}],"text":"Likewise, hypoxia preconditioning can also improve the proliferation and therapeutic efficacy of MSCs, as evident in bleomycin-induced pulmonary fibrosis model [36]."}